Journal article · 2021 · Open access

Design, Synthesis and Activity Evaluation of New Phthalazinone PARP Inhibitors

Mingqi Huang, Jinghui Ren, Yuhong Wang, Xixi Chen, Jia Yang, Tu Tang, Zhenyong Yang, Xiaojing Li, Min Ji, Jin Cai

Chemical and Pharmaceutical Bulletin, 69(7), 620–629 · Published 30 June 2021 · DOI 10.1248/cpb.c20-01018

Open PDFView at the publisherCite this paper

In brief

“Design, Synthesis and Activity Evaluation of New Phthalazinone PARP Inhibitors” is a 2021 journal article by Mingqi Huang and 9 co-authors, published in Chemical and Pharmaceutical Bulletin. OpenAlex counts 15 citations as of 19 November 2026. It is open access: the full text is free to read at Chemical and Pharmaceutical Bulletin.

Citations
15
Most cited in
2025 (5)
Field-weighted impact
0.57
References
32
Authors
10

Abstract

Poly(ADP-ribose)polymerase (PARP) is a significant therapeutic target for the treatment of numerous human diseases. Olaparib has been approved as a PARP inhibitor. In this paper, a series of new compounds were designed and synthesized with Olaparib as the lead compound. In order to evaluate the inhibitory activities against PARP1 of the synthesized compounds, in vitro PARP1 inhibition assay and intracellular PARylation assay were conducted. The results showed that the inhibitory activities of the derivatives were related to the type of substituent and the length of alkyl chain connecting the aromatic ring. 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT)-based assay also proved that these compounds demonstrating strong inhibition to PARP1 also have high anti-proliferative activities against BRCA2-deficient cell line (Capan-1). Analysis of the entire results suggest that compound 23 with desirable inhibitory efficiency may hold promise for further in vivo exploration of PARP inhibition.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Huang, M., Ren, J., Wang, Y., Chen, X., Yang, J., Tang, T., Yang, Z., Li, X., Ji, M., & Cai, J. (2021). Design, Synthesis and Activity Evaluation of New Phthalazinone PARP Inhibitors. Chemical and Pharmaceutical Bulletin, 69(7), 620–629. https://doi.org/10.1248/cpb.c20-01018

MLA 9

Huang, Mingqi, et al. “Design, Synthesis and Activity Evaluation of New Phthalazinone PARP Inhibitors.” Chemical and Pharmaceutical Bulletin, vol. 69, no. 7, 2021, pp. 620–629. https://doi.org/10.1248/cpb.c20-01018.

Chicago

Huang, Mingqi, Jinghui Ren, Yuhong Wang, Xixi Chen, Jia Yang, Tu Tang, Zhenyong Yang, Xiaojing Li, Min Ji, and Jin Cai. 2021. “Design, Synthesis and Activity Evaluation of New Phthalazinone PARP Inhibitors.” Chemical and Pharmaceutical Bulletin 69 (7): 620–629. https://doi.org/10.1248/cpb.c20-01018.

Harvard

Huang, M. et al. (2021) ‘Design, Synthesis and Activity Evaluation of New Phthalazinone PARP Inhibitors’, Chemical and Pharmaceutical Bulletin, 69(7), pp. 620–629. doi:10.1248/cpb.c20-01018.

IEEE

M. Huang et al., “Design, Synthesis and Activity Evaluation of New Phthalazinone PARP Inhibitors,” Chemical and Pharmaceutical Bulletin, vol. 69, no. 7, pp. 620–629, 2021, doi: 10.1248/cpb.c20-01018.

BibTeX

@article{huang2021design,
  title     = {{Design, Synthesis and Activity Evaluation of New Phthalazinone PARP Inhibitors}},
  author    = {Huang, Mingqi and Ren, Jinghui and Wang, Yuhong and Chen, Xixi and Yang, Jia and Tang, Tu and Yang, Zhenyong and Li, Xiaojing and Ji, Min and Cai, Jin},
  journal   = {Chemical and Pharmaceutical Bulletin},
  year      = {2021},
  volume    = {69},
  number    = {7},
  pages     = {620--629},
  doi       = {10.1248/cpb.c20-01018},
  url       = {https://doi.org/10.1248/cpb.c20-01018}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202122
202211
202322
202411
202555
202644

Its field-weighted citation impact is 0.57: it has been cited 0.57 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy

  • PARP inhibitors
  • phthalazinone derivatives
  • PARP1 inhibition
  • olaparib
  • Capan-1 cells
  • antiproliferative activity
  • structure-activity relationship
  • alkyl chain length

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Huang, M., Ren, J., Wang, Y., Chen, X., Yang, J., Tang, T., Yang, Z., Li, X., Ji, M., & Cai, J. (2021). Design, Synthesis and Activity Evaluation of New Phthalazinone PARP Inhibitors. Chemical and Pharmaceutical Bulletin, 69(7), 620–629. https://doi.org/10.1248/cpb.c20-01018

How many times has this paper been cited?

15 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Chemical and Pharmaceutical Bulletin: sign in and open the PDF from this page.

Who wrote this paper?

Mingqi Huang, Jinghui Ren, Yuhong Wang, Xixi Chen, Jia Yang, Tu Tang, Zhenyong Yang, Xiaojing Li, Min Ji, Jin Cai.

What is the DOI of this paper?

10.1248/cpb.c20-01018, permanently at https://doi.org/10.1248/cpb.c20-01018. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.